CITIUS PHARMACEU

CTXR NASDAQ
1.080
+0.010
+0.00%
已收盘, 16:47 08/22 EDT
开盘
1.080
昨收
1.080
最高
1.100
最低
1.074
成交量
8,029
成交均量(3M)
8.73万
52周最高
2.520
52周最低
0.8582
换手率
0.04%
市值
2,384.18万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供CITIUS PHARMACEU CTXR股票价格,CITIUS PHARMACEU股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. Its product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream. The Company's Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. The Company's Hydrocortisone-Lidocaine topical formulation provides anti-inflammation and anesthetic relief to persons suffering from hemorrhoids. Its Mino-Lok product for the treatment of catheter related bloodstream infections has completed Phase IIb and is entering Phase III trials. It is reformulating Hydrocortisone-Lidocaine product and will be entering Phase IIb trials in 2017. As of September 30, 2016, the Company had not generate any revenues.
展开 >

最近浏览

名称
价格
涨跌幅